Search Within

Computational Oncology Service

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (382)
  2. Meeting Abstract (239)
  3. Editorial (8)
  4. Review (8)
  5. Book Section (1)
  6. Conference Paper (1)
  7. Research Letter (1)
Groups
  1. Epidemiology and Biostatistics (640)
  2. Human Oncology and Pathogenesis Program (640)
  3. GSK Faculty (639)
  4. Department of Medicine (470)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (465)
  6. Solid Tumor Oncology Division (411)

More Groups

People
  1. Nikolaus Schultz (486)
  2. Michael Berger (177)
  3. David Solit (165)
  4. Jianjiong Gao (110)
  5. Marc Ladanyi (98)
  6. Francisco Sanchez Vega (91)

More People

Years
  1. 2025 (21)
  2. 2024 (47)
  3. 2023 (53)
  4. 2022 (76)
  5. 2021 (49)
  6. 2020 (75)

More Years

Publications
  1. Journal of Clinical Oncology (98)
  2. Cancer Research (66)
  3. Clinical Cancer Research (46)
  4. Nature Communications (27)
  5. Blood (26)
  6. Nature (26)

More Publications

Publishers
  1. American Association for Cancer Research (144)
  2. American Society of Clinical Oncology (115)
  3. Nature Publishing Group (97)
  4. Oxford University Press (39)
  5. Cell Press (37)
  6. American Society of Hematology (30)

More Publishers

Results (640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic and metabolic hallmarks of SDH- and FH-deficient renal cell carcinomas
    Journal Article

    Yoo, A.; Tang, C.; Zucker, M.; Fitzgerald, K.; DiNatale, R. G.; Rappold, P. M.; Weiss, K.; Freeman, B.; Lee, C. H.; Schultz, N.; more...
    European Urology Focus (2022)

    Fulltext@MSK | Save
  • Genomic alterations in ALK fusion-positive non-small cell lung cancer (NSCLC) patients with brain metastases
    Meeting Abstract

    Eichholz, J.; Miao, E.; Lebow, E.; Walch, H.; Flynn, J.; Zhang, Z.; Hubbeling, H.; Beal, K.; Moss, N.; Yu, K.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Characterizing the clinico-genomic landscape and outcomes of KRAS G12C mutated pancreas cancer
    Meeting Abstract

    Keane, F.; Park, W.; Varghese, A.; Balogun, F.; Yu, K.; El Dika, I.; Khalil, D.; Kelsen, D. P.; Reidy-Lagunes, D.; Ku, G. Y.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape
    Journal Article

    Golkaram, M.; Kuo, F.; Gupta, S.; Carlo, M. I.; Salmans, M. L.; Vijayaraghavan, R.; Tang, C.; Makarov, V.; Rappold, P.; Blum, K. A.; more...
    Genome Medicine (2022)

    Fulltext@MSK | Save
  • Comprehensive molecular characterization of gallbladder carcinoma and potential targets for intervention
    Journal Article

    Giraldo, N. A.; Drill, E.; Satravada, B. A.; El Dika, I.; Brannon, A. R.; Dermawan, J.; Mohanty, A.; Ozcan, K.; Chakravarty, D.; Benayed, R.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Genomic analysis and clinical correlations of non-small cell lung cancer (NSCLC) brain metastasis (BM)
    Meeting Abstract

    Skakodub, A.; Tringale, K. R.; Walch, H. S.; Vasudevan, H.; Eichholz, J.; Kelly, D. W.; Moss, N. S.; Yu, K. K. H.; Li, B. T.; Mueller, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinical and genomic characterization of ERBB2-altered gallbladder cancer
    Meeting Abstract

    Mondaca, S.; Schultz, N.; Roa, J. C.; Walch, H. S.; Sepulveda, S.; Harding, J. J.; Yaqubie, A.; Garcia, P.; Aguayo, G.; Nervi, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development
    Meeting Abstract

    Liu, D.; Murciano-Goroff, Y. R.; Jee, J.; Arcila, M. E.; Buonocore, D. J.; Gao, J.; Chakravarty, D.; Schram, A. M.; Callahan, M. K.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma
    Meeting Abstract

    Kinnaman, M. D.; Zaccaria, S.; Makohon-Moore, A.; Gundem, G.; Ossa, J. E. A.; Bouvier, N.; Dela Cruz, F. S.; Hameed, M.; Bender, J. L. G.; Tap, W. D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A robust, trial-agnostic gene signature for response to tyrosine kinase inhibition in ccRRCC
    Meeting Abstract

    Khaleel, S. S.; Liu, M.; Kuo, F.; Kotecha, R.; Lee, C. H.; Voss, M. H.; Motzer, R. J.; Hakimi, A. A.; Reznik, E.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save